Christopher Murray

Christopher Murray is an experienced medical affairs professional with a robust background in the pharmaceutical industry. Currently serving as an Associate at The Cable Company since August 2021, Christopher previously held significant leadership roles, including Senior Medical Director at Pfizer, where responsibilities centered around initiatives for XELJANZ in rheumatoid arthritis, and at Genzyme, overseeing global medical communications for multiple sclerosis products. Other notable positions include Senior Director at Ironwood Pharmaceuticals and Senior Director at Genzyme, managing publication strategies and medical affairs for various products. Christopher's career also includes pivotal roles at Wyeth Pharmaceuticals, where contributions involved medical affairs for a range of musculoskeletal products. Christopher earned a Ph.D. in Pharmacology from Temple University and a B.S. in Biochemistry from Penn State University.